Antioxidative and anti-inflammatory properties of cannabidiol
S Atalay, I Jarocka-Karpowicz, E Skrzydlewska - Antioxidants, 2019 - mdpi.com
Cannabidiol (CBD) is one of the main pharmacologically active phytocannabinoids of
Cannabis sativa L. CBD is non-psychoactive but exerts a number of beneficial …
Cannabis sativa L. CBD is non-psychoactive but exerts a number of beneficial …
Cannabidiol for pain treatment: focus on pharmacology and mechanism of action
J Mlost, M Bryk, K Starowicz - International journal of molecular sciences, 2020 - mdpi.com
Cannabis has a long history of medical use. Although there are many cannabinoids present
in cannabis, Δ9tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) are the two …
in cannabis, Δ9tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) are the two …
[HTML][HTML] Molecular targets of cannabidiol in neurological disorders
Cannabis has a long history of anecdotal medicinal use and limited licensed medicinal use.
Until recently, alleged clinical effects from anecdotal reports and the use of licensed …
Until recently, alleged clinical effects from anecdotal reports and the use of licensed …
Alternatively activated microglia and macrophages in the central nervous system
R Franco, D Fernández-Suárez - Progress in neurobiology, 2015 - Elsevier
Macrophages are important players in the fight against viral, bacterial, fungal and parasitic
infections. From a resting state they may undertake two activation pathways, the classical …
infections. From a resting state they may undertake two activation pathways, the classical …
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
The endocannabinoid system (ECS) regulates multiple physiological processes, including
cutaneous cell growth and differentiation. Here, we explored the effects of the major …
cutaneous cell growth and differentiation. Here, we explored the effects of the major …
Therapeutic potential of cannabidiol (CBD) for skin health and disorders
SM Baswan, AE Klosner, K Glynn… - Clinical, cosmetic and …, 2020 - Taylor & Francis
Though there is limited research confirming the purported topical benefits of cannabinoids, it
is certain that cutaneous biology is modulated by the human endocannabinoid system …
is certain that cutaneous biology is modulated by the human endocannabinoid system …
[HTML][HTML] Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1
L Casares, V García, M Garrido-Rodríguez, E Millán… - Redox biology, 2020 - Elsevier
Cannabidiol (CBD) is a major non-psychotropic phytocannabinoid that attracted a great
attention for its therapeutic potential against different pathologies including skin diseases …
attention for its therapeutic potential against different pathologies including skin diseases …
Molecular and cellular mechanisms of action of cannabidiol
Cannabidiol (CBD) is the primary non-psychoactive chemical from Cannabis Sativa, a plant
used for centuries for both recreational and medicinal purposes. CBD lacks the psychotropic …
used for centuries for both recreational and medicinal purposes. CBD lacks the psychotropic …
[HTML][HTML] Cannabinoids as therapeutic agents in cancer: current status and future implications
B Chakravarti, J Ravi, RK Ganju - Oncotarget, 2014 - ncbi.nlm.nih.gov
The pharmacological importance of cannabinoids has been in study for several years.
Cannabinoids comprise of (a) the active compounds of the Cannabis sativa plant,(b) …
Cannabinoids comprise of (a) the active compounds of the Cannabis sativa plant,(b) …
Single nucleus transcriptomics of ventral midbrain identifies glial activation associated with chronic opioid use disorder
J Wei, TY Lambert, A Valada, N Patel, K Walker… - Nature …, 2023 - nature.com
Dynamic interactions of neurons and glia in the ventral midbrain mediate reward and
addiction behavior. We studied gene expression in 212,713 ventral midbrain single nuclei …
addiction behavior. We studied gene expression in 212,713 ventral midbrain single nuclei …